Ataxin 1 and ataxin 3 in neuronal intranuclear inclusion disease
- PMID: 10443897
- DOI: 10.1002/1531-8249(199908)46:2<271::aid-ana21>3.0.co;2-m
Ataxin 1 and ataxin 3 in neuronal intranuclear inclusion disease
Abstract
Neuronal intranuclear inclusion disease (NIID) is a multisystem neurodegenerative disorder characterized by large intranuclear aggregates in neurons of the central and peripheral nervous system. These ubiquitinated intranuclear inclusions are morphologically similar to the intraneuronal aggregates that have been identified in the CAG/polyglutamine expansion diseases. As rare aggregates in NIID contain a polyglutamine epitope, we further investigated the relationship between this disease and the CAG/polyglutamine expansion diseases. Here, we show that ataxin 1 and ataxin 3 proteins are recruited into aggregates in NIID in the absence of a CAG expansion in the SCA1 and SCA3 genes. These data support an association of NIID with the polyglutamine disorders and provide evidence of in vivo recruitment of proteins with polyglutamine tracts into intraneuronal aggregates.
Similar articles
-
Recruitment of nonexpanded polyglutamine proteins to intranuclear aggregates in neuronal intranuclear hyaline inclusion disease.J Neuropathol Exp Neurol. 2001 Apr;60(4):369-76. doi: 10.1093/jnen/60.4.369. J Neuropathol Exp Neurol. 2001. PMID: 11305872
-
Non-expanded polyglutamine proteins in intranuclear inclusions of hereditary ataxias--triple-labeling immunofluorescence study.Acta Neuropathol. 2001 Aug;102(2):149-52. doi: 10.1007/s004010100364. Acta Neuropathol. 2001. PMID: 11563629
-
Promyelocytic leukemia protein is redistributed during the formation of intranuclear inclusions independent of polyglutamine expansion: an immunohistochemical study on Marinesco bodies.J Neuropathol Exp Neurol. 2002 Nov;61(11):984-91. doi: 10.1093/jnen/61.11.984. J Neuropathol Exp Neurol. 2002. PMID: 12430715
-
Progress in pathogenesis studies of spinocerebellar ataxia type 1.Philos Trans R Soc Lond B Biol Sci. 1999 Jun 29;354(1386):1079-81. doi: 10.1098/rstb.1999.0462. Philos Trans R Soc Lond B Biol Sci. 1999. PMID: 10434309 Free PMC article. Review.
-
Spinocerebellar ataxia type 1--modeling the pathogenesis of a polyglutamine neurodegenerative disorder in transgenic mice.J Neuropathol Exp Neurol. 2000 Apr;59(4):265-70. doi: 10.1093/jnen/59.4.265. J Neuropathol Exp Neurol. 2000. PMID: 10759181 Review.
Cited by
-
Ubiquitin/proteasome pathway impairment in neurodegeneration: therapeutic implications.Apoptosis. 2010 Nov;15(11):1292-311. doi: 10.1007/s10495-010-0466-z. Apoptosis. 2010. PMID: 20131003 Free PMC article. Review.
-
Small ubiquitin-like modifier (SUMO) modification of the androgen receptor attenuates polyglutamine-mediated aggregation.J Biol Chem. 2009 Aug 7;284(32):21296-306. doi: 10.1074/jbc.M109.011494. Epub 2009 Jun 4. J Biol Chem. 2009. PMID: 19497852 Free PMC article.
-
Neuronal intranuclear inclusion disease without polyglutamine inclusions in a child.J Neuropathol Exp Neurol. 2005 Jun;64(6):545-52. doi: 10.1093/jnen/64.6.545. J Neuropathol Exp Neurol. 2005. PMID: 15977647 Free PMC article.
-
The androgen receptor's CAG/glutamine tract in mouse models of neurological disease and cancer.J Alzheimers Dis. 2008 Jun;14(2):247-55. doi: 10.3233/jad-2008-14212. J Alzheimers Dis. 2008. PMID: 18560135 Free PMC article.
-
Role of dynamic and mitochondrial mutations in neurodegenerative diseases with ataxia: lower repeats and LNAs at multiple loci as alternative pathogenesis.J Mol Neurosci. 2014 Dec;54(4):837-47. doi: 10.1007/s12031-014-0431-3. Epub 2014 Oct 12. J Mol Neurosci. 2014. PMID: 25303857
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials